AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

Constellation Brands (STZ) stock rises ahead of the Modelo maker's earnings report. AstraZeneca (AZN) CEO reportedly wants to ...

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...